We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$48.3B
AUM Growth
-$47.5M
Cap. Flow
+$293M
Cap. Flow %
0.61%
Top 10 Hldgs %
19.42%
Holding
2,220
New
160
Increased
1,052
Reduced
474
Closed
103

Sector Composition

Rank Sector Weight
1 Technology 23.22%
2 Financials 13.94%
3 Healthcare 12.69%
4 Consumer Discretionary 11.51%
5 Communication Services 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOPE icon
1701
Grand Canyon Education
LOPE
$3.79B
$493K ﹤0.01%
5,605
+129
+2% +$11.5K
OLLI icon
1702
Ollie's Bargain Outlet
OLLI
$4.7B
$493K ﹤0.01%
8,175
+382
+5% +$30.9K
TBPH icon
1703
Theravance Biopharma
TBPH
$878M
$485K ﹤0.01%
65,600
WEN icon
1704
Wendy's
WEN
$1.65B
$484K ﹤0.01%
22,334
+1,050
+5% +$23.9K
VSAT icon
1705
Viasat
VSAT
$11.4B
$480K ﹤0.01%
8,715
+1,319
+18% +$67.4K
FHB icon
1706
First Hawaiian
FHB
$3.39B
$479K ﹤0.01%
16,322
+795
+5% +$22.1K
LAW icon
1707
CS Disco
LAW
$297M
$479K ﹤0.01%
+10,000
New +$506K
PASG icon
1708
Passage Bio
PASG
$14.7M
$478K ﹤0.01%
2,400
+204
+9% +$48.6K
PHAT icon
1709
Phathom Pharmaceuticals
PHAT
$743M
$478K ﹤0.01%
14,900
QVCGA
1710
DELISTED
QVC Group Inc Series A
QVCGA
$477K ﹤0.01%
936
+44
+5% +$24.8K
ALT icon
1711
Altimmune
ALT
$560M
$475K ﹤0.01%
42,000
SABR icon
1712
Sabre
SABR
$892M
$472K ﹤0.01%
39,878
+1,877
+5% +$21.3K
BHF icon
1713
Brighthouse Financial
BHF
$3.42B
$469K ﹤0.01%
10,366
+88
+0.9% +$3.97K
ALSN icon
1714
Allison Transmission
ALSN
$10.2B
$466K ﹤0.01%
13,185
+175
+1% +$6.68K
ADPT icon
1715
Adaptive Biotechnologies
ADPT
$3.89B
$464K ﹤0.01%
13,643
+649
+5% +$23.5K
FNB icon
1716
FNB Corp
FNB
$6.88B
$464K ﹤0.01%
39,947
+1,981
+5% +$22.8K
AVT icon
1717
Avnet
AVT
$7.87B
$463K ﹤0.01%
12,534
+590
+5% +$23.3K
JBGS
1718
JBG SMITH
JBGS
$692M
$460K ﹤0.01%
15,534
-14,275
-48% -$441K
BCAB icon
1719
BioAtla
BCAB
$5.73M
$459K ﹤0.01%
312
NUVB icon
1720
Nuvation Bio
NUVB
$2.14B
$459K ﹤0.01%
+46,200
New +$419K
BTAI icon
1721
BioXcel Therapeutics
BTAI
$34.9M
$458K ﹤0.01%
944
H icon
1722
Hyatt Hotels
H
$16.9B
$458K ﹤0.01%
5,934
+1,100
+23% +$82.9K
HHH icon
1723
Howard Hughes
HHH
$4.04B
$456K ﹤0.01%
5,453
+255
+5% +$22K
IOVA icon
1724
Iovance Biotherapeutics
IOVA
$2.95B
$455K ﹤0.01%
18,463
+1,121
+6% +$26.4K
FTDR icon
1725
Frontdoor
FTDR
$5.83B
$451K ﹤0.01%
10,752
-156,195
-94% -$7.13M

Similar funds

State of Wisconsin Investment Board's Q3 2021 Portfolio in Review

As of Q3 2021, State of Wisconsin Investment Board held 2,220 positions worth $48.3B, down 0.1% from $48.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

State of Wisconsin Investment Board's Q3 2021 filing shows 160 new, 1,052 increased, 474 reduced and 103 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 438,532 shares worth $32.6M. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $177M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • State of Wisconsin Investment Board's largest Q3 2021 buy was iShares Core MSCI EAFE ETF: 438,532 shares worth $32.6M.
  • State of Wisconsin Investment Board added most to Pfizer in Q3 2021, an estimated $94.9M increase.
  • State of Wisconsin Investment Board's biggest Q3 2021 reduction was Royal Dutch Shell PLC ADS Class B, cutting an estimated $177M.
  • State of Wisconsin Investment Board fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $103M.
  • State of Wisconsin Investment Board's ten largest holdings make up 19% of its $48.3B portfolio in Q3 2021.
  • State of Wisconsin Investment Board opened 160 new positions and closed 103 in Q3 2021.
  • State of Wisconsin Investment Board's portfolio value fell 0.1% quarter-over-quarter to $48.3B.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2021, filed 12 Nov 2021.